Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.75
- Piotroski Score 3.00
- Grade Overweight
- Symbol (PFE)
- Company Pfizer Inc.
- Price $28.58
- Changes Percentage (0.25%)
- Change $0.07
- Day Low $28.28
- Day High $28.77
- Year High $34.62
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
- Last Earnings 06/26/2024
- Ex-Dividend for 5/16 Dividend 07/26/2024
- Dividend Payable 09/03/2024
- Today N/A
- Next Earnings (Estimated) 10/28/2024
- Fiscal Year End N/A
- Average Stock Price Target $46.00
- High Stock Price Target $70.00
- Low Stock Price Target $20.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.05
- Trailing P/E Ratio -571.6
- Forward P/E Ratio -571.6
- P/E Growth -571.6
- Net Income $2.12 B
Income Statement
Quarterly
Annual
Latest News of PFE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Pfizer Inc. (PFE) The Best Beaten Down Dividend Stock to Invest in Now?
The article discusses the appeal of dividend stocks amid market shifts and the impact of interest rate changes. Pfizer Inc. is highlighted as a beaten-down dividend stock with potential, despite chall...
By Yahoo! Finance | 1 day ago -
Is Pfizer Inc. (PFE) the Best Cancer Stock to Buy Now?
The global oncology market is rapidly expanding, with cancer drug spending projected to surpass $300 billion by 2032. Pfizer Inc. (NYSE:PFE) is a key player in the field, offering innovative cancer tr...
By Yahoo! Finance | 3 days ago -
Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers
Short sellers profit from declining stock values through a strategy known as short selling. Despite market highs, short sellers made $10 billion in 2Q 2024. Pfizer Inc. (NYSE:PFE) ranks 7th in afforda...
By Yahoo! Finance | 1 week ago
